Research & Innovation at the Bass Center

Because childhood cancers are so rare, most young patients are referred here because of our expertise and experience. At Lucile Packard Children's Hospital Stanford, we have a pediatric cancer treatment and research program that’s known globally for the treatment of non-Hodgkin's lymphoma, Hodgkin's disease, leukemia and brain tumors.

As a part of the NCI-designated Stanford Cancer Institute, the Bass Center works with some of the brightest and most innovative physician-scientists. In addition, our physicians hold leadership roles in the national clinical research consortium Children's Oncology Group (COG). This group — representing the merger of four national pediatric cancer research groups — designs and evaluates cancer therapies through large clinical trials. We also conduct a number of trials of experimental drugs that can offer new treatment options for patients who have failed other therapies.

Genome Sequencing for Childhood Cancers

Lucile Packard Children’s Hospital Stanford has assembled a team of world-class clinicians, cancer biologists, computer scientists and clinical genetics experts to utilize high-throughput sequencing to improve the care of pediatric patients with cancer. Learn more about our unique approach.

Unlocking the Promise of T Cell Therapy

The T cell is one of our best weapons against cancer, and at Lucile Packard Children’s Hospital Stanford, we’re exploring new ways to harness it to improve outcomes for our patients.

CAR T-cell therapies turn T cells that are normally powerless against cancer into T cells that can not only find cancer, they can kill it. Leukemia patients with two or more bone marrow relapses may be eligible for a trial to determine the efficacy and safety of investigational CAR T-cell therapy CTL019. Lucile Packard Children’s Hospital Stanford is the only hospital in Northern California offering this pediatric trial.

Longer-term, Stanford cancer immunotherapy experts like Crystal Mackall, MD, are working to engineer T cells to prompt a cancer patient’s body to attack tumors that have stopped responding to traditional chemotherapy. They are also studying how to get T cells to live longer.

These are just a few of many cutting-edge clinical trials happening at Lucile Packard Children’s Hospital Stanford. To find out more about these trials and more than 50 others, see our list of clinical trials.

For more information about our research and clinical trials, call (650) 497-8953.

Stanford Cancer Institute logo